ORIGINAL ARTICLESCoronary revascularisation in insulin-dependent diabetic patients with chronic renal failure
References (22)
- et al.
Natural history of asymptomatic coronary arteriographic lesions in diabetic patients with end-stage renal disease
Am J Med
(1978) - et al.
Evaluation of cardiovascular risk for renal transplantation in diabetic patients
Am J Med
(1986) - et al.
Asymptomatic myocardial ischemia in diabetic patients
Am J Med
(1986) - et al.
Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation
Am J Med
(1991) - et al.
Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation
Am J Surg
(1983) - et al.
Adrenergic modulation of potassium metabolism in uremia
Kidney Int
(1990) The United States Renal Data System 1990 Annual Data Report
(1990)- et al.
Asymptomatic coronary artery disease: angiographic assessment of diabetes evaluated for renal transplantation
Circulation
(1978) - et al.
Coronary artery disease in 100 diabetics with end-stage renal failure
Transplant Proc
(1984) - et al.
Pre-transplant coronary arteriography for diabetic renal transplant recipients
Transplant Proc
(1987)
Cited by (315)
Prognostic value of computed tomography derived fractional flow reserve for predicting cardiac events and mortality in kidney transplant candidates
2022, Journal of Cardiovascular Computed TomographyOutcomes of Interventional Management of Coronary Artery Disease in Kidney Transplant Recipients
2022, Transplantation ProceedingsCitation Excerpt :There was no difference noted in mortality in patients receiving dialysis [21]. In another smaller randomized trial specifically among patients with ESRD and diabetes with asymptomatic CAD, the group that was revascularized had markedly superior outcomes compared with those only managed medically [22]. Although these studies offer some support that patients with ESRD may benefit from early revascularization, it is difficult to generalize to our population.
Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial
2021, Journal of the American College of CardiologyCitation Excerpt :We believe the findings of the present study and those of the overall ISCHEMIA-CKD trial should prompt a re-examination of the current clinical practice of preemptive noninvasive assessment and coronary revascularization of potential kidney transplant recipients with chronic coronary disease, particularly those with asymptomatic myocardial ischemia and those without left main CAD. The results of this analysis differ from the prior, smaller study of Manske et al (1) that set the foundation for pre-emptive revascularization among potential kidney transplant recipients with stable CAD. In the present study and the overall ISCHEMIA-CKD trial, the invasive and conservative strategies were equally efficacious; however, a crucial feature of the trial was the implementation of optimal medical therapy in both groups, including intensive treatment of dyslipidemia, with high treatment goal achievement (7).
Treating Myocardial Ischemia Before Kidney Transplantation: Time for a Reappraisal
2021, Journal of the American College of Cardiology